National Sales Director Rheumatology Field US R1605533 Posted

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Field Medical organization embodies our medical mission to be recognized as the trusted partner for internal stake holders and the healthcare community, driving scientific exchange to enhance medical education, data generation, insight generation, and patients’ access to medicine. The Director, Field Medical (FM) Immunology (IMM) – Rheumatology role is field-based and focused on leading a team of Field Medical professionals.

Direct reports will include field-based Regional Associate Directors (RADs) and Region Directors (RDs) who manage a team of field-based Immunology Medical Science Liaisons (MSLs) focused on Rheumatology. The FM Director will be responsible for oversight of RADs/RDs and MSLs in support of BMS Immunology medicines, specifically in Rheumatic Diseases, and all phases of assets associated clinical trials and launch.

• Ensure team’s ability to drive scientific exchange with Thought Leaders, appropriate HCPs, and access stakeholders, within a given geography to answer scientific, unsolicited product and HEOR related questions
• Support and evaluate MSLs ability to effectively present information to HCPs and ability to respond to questions, ensuring medical accuracy and compliance with local procedures, ethical and legal guidelines and directives
• Actively assess the medical landscape by meeting with Thought Leaders to understand their needs and expertise. Continuously update own knowledge in treatment strategies, products, unmet medical needs, clinical trials and scientific activities. Understand the competitive landscape and actively prepare to address informational needs of customers.
• Ensure MSLs capability to collect and provide meaningful medical insights back to the medical and commercial organizations to be actioned in support of strategy development.
• Provide direction to overall execution of the Field Medical plan
• Ensures FM team activities are aligned with the US Medical Strategy Plan
• Ensure matrix engagement

• Ensure active support for CRO sponsored studies as agreed with medical management and as defined by the study scope document
• Oversee appropriate support of BMS sponsored as well as Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites for BMS sponsored trials) to facilitate patient recruitment and/or discissions around the safe and effective use of BMS investigational products, as agreed with local medical management and as defined by the study scope document
• Oversee collaboration with the clinical organization to enhance patient enrolment in BMS-sponsored clinical trials by identifying appropriate clinical trial sites, interacting with investigators in ongoing studies, and educating the community for referrals
• Oversee recommendations and insights to clinical development team on study and site feasibilities for BMS sponsored trials within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with local medical management
• Oversee and ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events
• Ensure active support of MSL as a primary liaison to investigators interested in developing and performing investigator-sponsored research (ISR); helping to facilitate support to HCPs in the ISR submission process when needed and as agreed upon with home office medical and US Market Guiding Principles